Loading...
High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial
INTRODUCTION: About one-third of patients with severe ulcerative colitis (UC) do not respond to corticosteroid therapy and receive rescue therapy with infliximab or cyclosporine. Up to 20% of such patients fail to respond to rescue therapy and undergo colectomy. OBJECTIVE: We investigated the outcom...
Saved in:
| Published in: | Perm J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The Permanente Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7931990/ https://ncbi.nlm.nih.gov/pubmed/33482946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/19.166 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|